CITADEL ADVISORS LLC - 14 Jan 2026 SCHEDULE 13G Report for PLIANT THERAPEUTICS, INC. Common stock, par value $0.0001 per share (the "Shares") (PLRX)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
PLIANT THERAPEUTICS, INC. Common stock, par value $0.0001 per share (the "Shares")
Symbol
PLRX
Shares outstanding
61,059,490 shares
Disclosed Ownership
2,991,915 shares
Ownership
4.9%
Form type
SCHEDULE 13G
Filing time
22 Jan 2026, 19:02:44 UTC
Date of event
14 Jan 2026
Next filing
30 Jan 2026
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 3.4% 2,099,798 0 2,099,798 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 3.4% 2,099,798 0 2,099,798 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 3.4% 2,099,798 0 2,099,798 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 1.4% 863,391 0 863,391 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities Group LP 1.5% 892,117 0 892,117 /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities GP LLC 1.5% 892,117 0 892,117 /s/ Seth Levy Seth Levy, Authorized Signatory
Kenneth Griffin 4.9% 2,991,915 0 2,991,915 /s/ Seth Levy Seth Levy, attorney-in-fact*